Johns Hopkins HIV Guide
Maraviroc
INDICATIONS
FDA
FDA
Only recommended for patients with CCR5-tropic HIV-1 infection.
- Used with other ARVs in ART-experienced adult patients infected with CCR5 (R5)-tropic HIV-1.
- Used in combination with other ARVs in ART-naive adult patients infected with CCR5 (R5)-tropic HIV-1 (not a DHHS preferred first-line agent)
- FDA-approved for adults and pediatric patients 2 years and older weighing at least 2 kg.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: July 8, 2023
Citation
Auwaerter, Paul G, and Paul A Pham. "Maraviroc." Johns Hopkins HIV Guide, The Johns Hopkins University, 2023. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545128/all/Maraviroc.
Auwaerter PG, Pham PA. Maraviroc. Johns Hopkins HIV Guide. The Johns Hopkins University; 2023. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545128/all/Maraviroc. Accessed October 31, 2025.
Auwaerter, P. G., & Pham, P. A. (2023). Maraviroc. In Johns Hopkins HIV Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545128/all/Maraviroc
Auwaerter PG, Pham PA. Maraviroc [Internet]. In: Johns Hopkins HIV Guide. The Johns Hopkins University; 2023. [cited 2025 October 31]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545128/all/Maraviroc.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Maraviroc
ID - 545128
A1 - Auwaerter,Paul,M.D.
AU - Pham,Paul,Pharm.D. BCPS
Y1 - 2023/07/08/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545128/all/Maraviroc
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
